FDA Releases Draft Guidance for Industry on Integration of Dose-Counting Mechanisms into MDI Drug Products

Summary

The Food and Drug Administration (FDA) has released a draft guidance for industry that recommends incorporating dose-counters into metered-dose inhalers (MDIs) to help patients identify when MDIs are no longer delivering reliable doses, aiming to enhance the use of these devices for treating lung diseases.